Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectoris.

Abstract

Atrial natriuretic peptide (ANP) is reported to dilate a major coronary artery in both experimental animals and humans. Spasm of a major coronary artery is the cause of variant angina pectoris and can be induced by hyperventilation. The effect of the ANP infusion on anginal attack induced by hyperventilation was studied in patients with variant angina… (More)

Topics

Cite this paper

@article{Tanaka1993SuppressionOH, title={Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectoris.}, author={H. Tanaka and H. Yasue and Maiko Yoshimura and Eugene T. Morita and Michihisa Jougasaki and H. Kato and Y. Miyao and Kentaro Nakao}, journal={The American journal of cardiology}, year={1993}, volume={72 2}, pages={128-33} }